Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
kymriah
4
×
life sciences
national blog main
boston blog main
boston top stories
gilead sciences
medicare
national
national top stories
novartis
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
yescarta
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug prices
fda
gene therapy
immuno-oncology
immunotherapy
indiana blog main
indiana top stories
kite pharma
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
drug
acquisitions
adding
airport
albert
annual
apocalypse
beds
bets
biggest
bio
boost
bourla
cancer
celgene
ceo
chemistry
cmc
company
consistent
controls
crispr
days
ensure
expensive
fallout
far
fda
future
gene
gilead
gone
home
imports
j.p
jpm
lack
maker
manufacturing
maps
Language
unknown
unset
Current search:
kymriah
×
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
